NewsBenzinga메디시노바, 근위축성 측삭 경화증 치료제 MN-166 평가를 위한 COMBAT-ALS 2B/3상 임상시험의 이중맹검 단계에서 마지막 환자 방문 완료 메디시노바, 근위축성 측삭 경화증 치료제 MN-166 평가를 위한 COMBAT-ALS 2B/3상 임상시험의 이중맹검 단계에서 마지막 환자 방문 완료 Benzinga 2026.09.24 10:10 (GMT+0) Open on Benzinga Other news Tom Lee: This Crypto Bull Market Could Surpass Previous Cycles, With Tokenization and AI Adding New Momentum Ondo Partners with BlackRock to Launch Tokenized "Smart Portfolio" Link Streamex Converts Interest Into Capital as GLDY Investment Strategy Secures $1M+ Institutional Allocation Exclusive | BlackRock Investment Portfolios Debut on the Blockchain as Digital Tokens Rodman & Renshaw Initiates Coverage On Quince Therapeutics with Buy Rating, Announces Price Target of $70 What's Going On With Oracle Stock Thursday?
Tom Lee: This Crypto Bull Market Could Surpass Previous Cycles, With Tokenization and AI Adding New Momentum
Streamex Converts Interest Into Capital as GLDY Investment Strategy Secures $1M+ Institutional Allocation
Rodman & Renshaw Initiates Coverage On Quince Therapeutics with Buy Rating, Announces Price Target of $70
